Stock EPRX EUPRAXIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Market Closed - Toronto S.E.
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.65 CAD -4.20% Intraday chart for Eupraxia Pharmaceuticals Inc. -6.41% -32.03%
May. 23 Eupraxia Pharmaceuticals Expanding RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT
May. 23 Eupraxia Pharmaceuticals Inc. Brief: Announcing Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT

Evolution of the average Target Price on Eupraxia Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

6820644af1e7f67f751b2be7d35e216.PlcRKhz2cxo005vsHzcDYsB4KY98ahBdRv86dZXxiUM.TDVXGlacBCNrnc2LeH51JJU7frw2BnFkB4gJHaWhxxJUOlQfWZxGU2aBrw~a57ac006f990271900e4f86c8dcd3dbe

Analyst Recommendations on Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Rated Outperform, $7 Target Price at Raymond James MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.65 CAD
Average target price
14.45 CAD
Spread / Average Target
+295.89%
High Price Target
16.5 CAD
Spread / Highest target
+352.05%
Low Price Target
12.4 CAD
Spread / Lowest Target
+239.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eupraxia Pharmaceuticals Inc.

Raymond James

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EPRX Stock
  4. Consensus Eupraxia Pharmaceuticals Inc.